Global Phenprocoumon Market Growth 2023-2029

February 2023 | 94 pages | ID: GC5BD8227DBCEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Phenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is a long-acting oral anticoagulant drug, a derivative of coumarin. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).

LPI (LP Information)' newest research report, the “Phenprocoumon Industry Forecast” looks at past sales and reviews total world Phenprocoumon sales in 2022, providing a comprehensive analysis by region and market sector of projected Phenprocoumon sales for 2023 through 2029. With Phenprocoumon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phenprocoumon industry.

This Insight Report provides a comprehensive analysis of the global Phenprocoumon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phenprocoumon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Phenprocoumon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phenprocoumon and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phenprocoumon.

The global Phenprocoumon market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Phenprocoumon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Phenprocoumon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Phenprocoumon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Phenprocoumon players cover Novartis, Mylan, Teva, Roche, Aspen Pharmacare, Acis Arzneimittel, W?rwag Pharma and Divis Labs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Phenprocoumon market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 5 mg
• 10 mg
• 25 mg
• 50 mg

Segmentation by application

• Venous Thrombosis
• Thromboembolism
• Pulmonary Embolism
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Mylan
• Teva
• Roche
• Aspen Pharmacare
• Acis Arzneimittel
• W?rwag Pharma
• Divis Labs

Key Questions Addressed in this Report

What is the 10-year outlook for the global Phenprocoumon market?

What factors are driving Phenprocoumon market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Phenprocoumon market opportunities vary by end market size?

How does Phenprocoumon break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Phenprocoumon Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Phenprocoumon by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Phenprocoumon by Country/Region, 2018, 2022 & 2029
2.2 Phenprocoumon Segment by Type
  2.2.1 5 mg
  2.2.2 10 mg
  2.2.3 25 mg
  2.2.4 50 mg
2.3 Phenprocoumon Sales by Type
  2.3.1 Global Phenprocoumon Sales Market Share by Type (2018-2023)
  2.3.2 Global Phenprocoumon Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Phenprocoumon Sale Price by Type (2018-2023)
2.4 Phenprocoumon Segment by Application
  2.4.1 Venous Thrombosis
  2.4.2 Thromboembolism
  2.4.3 Pulmonary Embolism
  2.4.4 Others
2.5 Phenprocoumon Sales by Application
  2.5.1 Global Phenprocoumon Sale Market Share by Application (2018-2023)
  2.5.2 Global Phenprocoumon Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Phenprocoumon Sale Price by Application (2018-2023)

3 GLOBAL PHENPROCOUMON BY COMPANY

3.1 Global Phenprocoumon Breakdown Data by Company
  3.1.1 Global Phenprocoumon Annual Sales by Company (2018-2023)
  3.1.2 Global Phenprocoumon Sales Market Share by Company (2018-2023)
3.2 Global Phenprocoumon Annual Revenue by Company (2018-2023)
  3.2.1 Global Phenprocoumon Revenue by Company (2018-2023)
  3.2.2 Global Phenprocoumon Revenue Market Share by Company (2018-2023)
3.3 Global Phenprocoumon Sale Price by Company
3.4 Key Manufacturers Phenprocoumon Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Phenprocoumon Product Location Distribution
  3.4.2 Players Phenprocoumon Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR PHENPROCOUMON BY GEOGRAPHIC REGION

4.1 World Historic Phenprocoumon Market Size by Geographic Region (2018-2023)
  4.1.1 Global Phenprocoumon Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Phenprocoumon Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Phenprocoumon Market Size by Country/Region (2018-2023)
  4.2.1 Global Phenprocoumon Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Phenprocoumon Annual Revenue by Country/Region (2018-2023)
4.3 Americas Phenprocoumon Sales Growth
4.4 APAC Phenprocoumon Sales Growth
4.5 Europe Phenprocoumon Sales Growth
4.6 Middle East & Africa Phenprocoumon Sales Growth

5 AMERICAS

5.1 Americas Phenprocoumon Sales by Country
  5.1.1 Americas Phenprocoumon Sales by Country (2018-2023)
  5.1.2 Americas Phenprocoumon Revenue by Country (2018-2023)
5.2 Americas Phenprocoumon Sales by Type
5.3 Americas Phenprocoumon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Phenprocoumon Sales by Region
  6.1.1 APAC Phenprocoumon Sales by Region (2018-2023)
  6.1.2 APAC Phenprocoumon Revenue by Region (2018-2023)
6.2 APAC Phenprocoumon Sales by Type
6.3 APAC Phenprocoumon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Phenprocoumon by Country
  7.1.1 Europe Phenprocoumon Sales by Country (2018-2023)
  7.1.2 Europe Phenprocoumon Revenue by Country (2018-2023)
7.2 Europe Phenprocoumon Sales by Type
7.3 Europe Phenprocoumon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Phenprocoumon by Country
  8.1.1 Middle East & Africa Phenprocoumon Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Phenprocoumon Revenue by Country (2018-2023)
8.2 Middle East & Africa Phenprocoumon Sales by Type
8.3 Middle East & Africa Phenprocoumon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phenprocoumon
10.3 Manufacturing Process Analysis of Phenprocoumon
10.4 Industry Chain Structure of Phenprocoumon

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Phenprocoumon Distributors
11.3 Phenprocoumon Customer

12 WORLD FORECAST REVIEW FOR PHENPROCOUMON BY GEOGRAPHIC REGION

12.1 Global Phenprocoumon Market Size Forecast by Region
  12.1.1 Global Phenprocoumon Forecast by Region (2024-2029)
  12.1.2 Global Phenprocoumon Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Phenprocoumon Forecast by Type
12.7 Global Phenprocoumon Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Phenprocoumon Product Portfolios and Specifications
  13.1.3 Novartis Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 Mylan
  13.2.1 Mylan Company Information
  13.2.2 Mylan Phenprocoumon Product Portfolios and Specifications
  13.2.3 Mylan Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Mylan Main Business Overview
  13.2.5 Mylan Latest Developments
13.3 Teva
  13.3.1 Teva Company Information
  13.3.2 Teva Phenprocoumon Product Portfolios and Specifications
  13.3.3 Teva Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Teva Main Business Overview
  13.3.5 Teva Latest Developments
13.4 Roche
  13.4.1 Roche Company Information
  13.4.2 Roche Phenprocoumon Product Portfolios and Specifications
  13.4.3 Roche Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Roche Main Business Overview
  13.4.5 Roche Latest Developments
13.5 Aspen Pharmacare
  13.5.1 Aspen Pharmacare Company Information
  13.5.2 Aspen Pharmacare Phenprocoumon Product Portfolios and Specifications
  13.5.3 Aspen Pharmacare Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Aspen Pharmacare Main Business Overview
  13.5.5 Aspen Pharmacare Latest Developments
13.6 Acis Arzneimittel
  13.6.1 Acis Arzneimittel Company Information
  13.6.2 Acis Arzneimittel Phenprocoumon Product Portfolios and Specifications
  13.6.3 Acis Arzneimittel Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Acis Arzneimittel Main Business Overview
  13.6.5 Acis Arzneimittel Latest Developments
13.7 W?rwag Pharma
  13.7.1 W?rwag Pharma Company Information
  13.7.2 W?rwag Pharma Phenprocoumon Product Portfolios and Specifications
  13.7.3 W?rwag Pharma Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 W?rwag Pharma Main Business Overview
  13.7.5 W?rwag Pharma Latest Developments
13.8 Divis Labs
  13.8.1 Divis Labs Company Information
  13.8.2 Divis Labs Phenprocoumon Product Portfolios and Specifications
  13.8.3 Divis Labs Phenprocoumon Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Divis Labs Main Business Overview
  13.8.5 Divis Labs Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Phenprocoumon Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Phenprocoumon Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5 mg
Table 4. Major Players of 10 mg
Table 5. Major Players of 25 mg
Table 6. Major Players of 50 mg
Table 7. Global Phenprocoumon Sales by Type (2018-2023) & (K Units)
Table 8. Global Phenprocoumon Sales Market Share by Type (2018-2023)
Table 9. Global Phenprocoumon Revenue by Type (2018-2023) & ($ million)
Table 10. Global Phenprocoumon Revenue Market Share by Type (2018-2023)
Table 11. Global Phenprocoumon Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Phenprocoumon Sales by Application (2018-2023) & (K Units)
Table 13. Global Phenprocoumon Sales Market Share by Application (2018-2023)
Table 14. Global Phenprocoumon Revenue by Application (2018-2023)
Table 15. Global Phenprocoumon Revenue Market Share by Application (2018-2023)
Table 16. Global Phenprocoumon Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Phenprocoumon Sales by Company (2018-2023) & (K Units)
Table 18. Global Phenprocoumon Sales Market Share by Company (2018-2023)
Table 19. Global Phenprocoumon Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Phenprocoumon Revenue Market Share by Company (2018-2023)
Table 21. Global Phenprocoumon Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Phenprocoumon Producing Area Distribution and Sales Area
Table 23. Players Phenprocoumon Products Offered
Table 24. Phenprocoumon Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Phenprocoumon Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Phenprocoumon Sales Market Share Geographic Region (2018-2023)
Table 29. Global Phenprocoumon Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Phenprocoumon Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Phenprocoumon Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Phenprocoumon Sales Market Share by Country/Region (2018-2023)
Table 33. Global Phenprocoumon Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Phenprocoumon Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Phenprocoumon Sales by Country (2018-2023) & (K Units)
Table 36. Americas Phenprocoumon Sales Market Share by Country (2018-2023)
Table 37. Americas Phenprocoumon Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Phenprocoumon Revenue Market Share by Country (2018-2023)
Table 39. Americas Phenprocoumon Sales by Type (2018-2023) & (K Units)
Table 40. Americas Phenprocoumon Sales by Application (2018-2023) & (K Units)
Table 41. APAC Phenprocoumon Sales by Region (2018-2023) & (K Units)
Table 42. APAC Phenprocoumon Sales Market Share by Region (2018-2023)
Table 43. APAC Phenprocoumon Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Phenprocoumon Revenue Market Share by Region (2018-2023)
Table 45. APAC Phenprocoumon Sales by Type (2018-2023) & (K Units)
Table 46. APAC Phenprocoumon Sales by Application (2018-2023) & (K Units)
Table 47. Europe Phenprocoumon Sales by Country (2018-2023) & (K Units)
Table 48. Europe Phenprocoumon Sales Market Share by Country (2018-2023)
Table 49. Europe Phenprocoumon Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Phenprocoumon Revenue Market Share by Country (2018-2023)
Table 51. Europe Phenprocoumon Sales by Type (2018-2023) & (K Units)
Table 52. Europe Phenprocoumon Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Phenprocoumon Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Phenprocoumon Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Phenprocoumon Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Phenprocoumon Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Phenprocoumon Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Phenprocoumon Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Phenprocoumon
Table 60. Key Market Challenges & Risks of Phenprocoumon
Table 61. Key Industry Trends of Phenprocoumon
Table 62. Phenprocoumon Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Phenprocoumon Distributors List
Table 65. Phenprocoumon Customer List
Table 66. Global Phenprocoumon Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Phenprocoumon Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Phenprocoumon Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Phenprocoumon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Phenprocoumon Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Phenprocoumon Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Phenprocoumon Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Phenprocoumon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Phenprocoumon Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Phenprocoumon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Phenprocoumon Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Phenprocoumon Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Phenprocoumon Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Phenprocoumon Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Novartis Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Phenprocoumon Product Portfolios and Specifications
Table 82. Novartis Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Mylan Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 86. Mylan Phenprocoumon Product Portfolios and Specifications
Table 87. Mylan Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Mylan Main Business
Table 89. Mylan Latest Developments
Table 90. Teva Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Phenprocoumon Product Portfolios and Specifications
Table 92. Teva Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Main Business
Table 94. Teva Latest Developments
Table 95. Roche Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Phenprocoumon Product Portfolios and Specifications
Table 97. Roche Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Roche Main Business
Table 99. Roche Latest Developments
Table 100. Aspen Pharmacare Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 101. Aspen Pharmacare Phenprocoumon Product Portfolios and Specifications
Table 102. Aspen Pharmacare Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Aspen Pharmacare Main Business
Table 104. Aspen Pharmacare Latest Developments
Table 105. Acis Arzneimittel Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 106. Acis Arzneimittel Phenprocoumon Product Portfolios and Specifications
Table 107. Acis Arzneimittel Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Acis Arzneimittel Main Business
Table 109. Acis Arzneimittel Latest Developments
Table 110. W?rwag Pharma Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 111. W?rwag Pharma Phenprocoumon Product Portfolios and Specifications
Table 112. W?rwag Pharma Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. W?rwag Pharma Main Business
Table 114. W?rwag Pharma Latest Developments
Table 115. Divis Labs Basic Information, Phenprocoumon Manufacturing Base, Sales Area and Its Competitors
Table 116. Divis Labs Phenprocoumon Product Portfolios and Specifications
Table 117. Divis Labs Phenprocoumon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Divis Labs Main Business
Table 119. Divis Labs Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Phenprocoumon
Figure 2. Phenprocoumon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Phenprocoumon Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Phenprocoumon Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Phenprocoumon Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5 mg
Figure 10. Product Picture of 10 mg
Figure 11. Product Picture of 25 mg
Figure 12. Product Picture of 50 mg
Figure 13. Global Phenprocoumon Sales Market Share by Type in 2022
Figure 14. Global Phenprocoumon Revenue Market Share by Type (2018-2023)
Figure 15. Phenprocoumon Consumed in Venous Thrombosis
Figure 16. Global Phenprocoumon Market: Venous Thrombosis (2018-2023) & (K Units)
Figure 17. Phenprocoumon Consumed in Thromboembolism
Figure 18. Global Phenprocoumon Market: Thromboembolism (2018-2023) & (K Units)
Figure 19. Phenprocoumon Consumed in Pulmonary Embolism
Figure 20. Global Phenprocoumon Market: Pulmonary Embolism (2018-2023) & (K Units)
Figure 21. Phenprocoumon Consumed in Others
Figure 22. Global Phenprocoumon Market: Others (2018-2023) & (K Units)
Figure 23. Global Phenprocoumon Sales Market Share by Application (2022)
Figure 24. Global Phenprocoumon Revenue Market Share by Application in 2022
Figure 25. Phenprocoumon Sales Market by Company in 2022 (K Units)
Figure 26. Global Phenprocoumon Sales Market Share by Company in 2022
Figure 27. Phenprocoumon Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Phenprocoumon Revenue Market Share by Company in 2022
Figure 29. Global Phenprocoumon Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Phenprocoumon Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Phenprocoumon Sales 2018-2023 (K Units)
Figure 32. Americas Phenprocoumon Revenue 2018-2023 ($ Millions)
Figure 33. APAC Phenprocoumon Sales 2018-2023 (K Units)
Figure 34. APAC Phenprocoumon Revenue 2018-2023 ($ Millions)
Figure 35. Europe Phenprocoumon Sales 2018-2023 (K Units)
Figure 36. Europe Phenprocoumon Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Phenprocoumon Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Phenprocoumon Revenue 2018-2023 ($ Millions)
Figure 39. Americas Phenprocoumon Sales Market Share by Country in 2022
Figure 40. Americas Phenprocoumon Revenue Market Share by Country in 2022
Figure 41. Americas Phenprocoumon Sales Market Share by Type (2018-2023)
Figure 42. Americas Phenprocoumon Sales Market Share by Application (2018-2023)
Figure 43. United States Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Phenprocoumon Sales Market Share by Region in 2022
Figure 48. APAC Phenprocoumon Revenue Market Share by Regions in 2022
Figure 49. APAC Phenprocoumon Sales Market Share by Type (2018-2023)
Figure 50. APAC Phenprocoumon Sales Market Share by Application (2018-2023)
Figure 51. China Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Phenprocoumon Sales Market Share by Country in 2022
Figure 59. Europe Phenprocoumon Revenue Market Share by Country in 2022
Figure 60. Europe Phenprocoumon Sales Market Share by Type (2018-2023)
Figure 61. Europe Phenprocoumon Sales Market Share by Application (2018-2023)
Figure 62. Germany Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Phenprocoumon Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Phenprocoumon Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Phenprocoumon Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Phenprocoumon Sales Market Share by Application (2018-2023)
Figure 71. Egypt Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Phenprocoumon Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Phenprocoumon in 2022
Figure 77. Manufacturing Process Analysis of Phenprocoumon
Figure 78. Industry Chain Structure of Phenprocoumon
Figure 79. Channels of Distribution
Figure 80. Global Phenprocoumon Sales Market Forecast by Region (2024-2029)
Figure 81. Global Phenprocoumon Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Phenprocoumon Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Phenprocoumon Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Phenprocoumon Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Phenprocoumon Revenue Market Share Forecast by Application (2024-2029)